probenecid has been researched along with acetaminophen in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (24.32) | 18.7374 |
1990's | 9 (24.32) | 18.2507 |
2000's | 10 (27.03) | 29.6817 |
2010's | 9 (24.32) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Duggin, GG; Mudge, GH | 1 |
Bito, LZ; Wallenstein, MC | 2 |
Arnold, L; Collins, C; Starmer, GA | 1 |
Dehner, EJ; Martin, ET; Schwartz, JB | 1 |
Kamali, F; Rawlins, MD | 1 |
Cretton, EM; Sommadossi, JP | 1 |
Ignarro, LJ; Wood, KS | 1 |
Bell, GD; Fry, JR; Kamali, F | 1 |
Abernethy, DR; Ameer, B; Greenblatt, DJ; Shader, RI | 1 |
Kim, CS; Mann, JD; O'Tuama, LA; Roe, CR | 1 |
Kamali, F | 1 |
Greenblatt, DJ; Harmatz, JS; Manis, M; Poorman, R; von Moltke, LL | 1 |
Cohen, SD; Emeigh Hart, SG; Khairallah, EA; Wyand, DS | 1 |
Brouwer, KL; Turner, KC | 1 |
Awazu, S; Hayashi, M; Iida, S; Mizuma, T; Sakuma-Sawada, N | 2 |
Elías, MM; Monasterolo, LA; Trumper, L | 1 |
Abe, F; Fujimoto, Y; Fukuda, M; Hasegawa, T; Kitaichi, K; Morishima, T; Takagi, K | 1 |
3 review(s) available for probenecid and acetaminophen
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for probenecid and acetaminophen
Article | Year |
---|---|
The effect of probenecid on paracetamol metabolism and pharmacokinetics.
Topics: Acetaminophen; Adult; Animals; Arabidopsis Proteins; Drug Interactions; Female; Glucosyltransferases; Half-Life; Humans; In Vitro Techniques; Male; Microsomes, Liver; Probenecid; Rats | 1993 |
33 other study(ies) available for probenecid and acetaminophen
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Renal tubular transport of paracetamol and its conjugates in the dog.
Topics: Acetaminophen; Animals; Biological Transport; Dogs; Female; Glomerular Filtration Rate; Glucuronates; Hydrogen-Ion Concentration; Kidney Tubules; Probenecid; Protein Binding; Sulfates | 1975 |
Prostaglandin E1-induced alterations in visually-evoked response and production of epileptiform activity.
Topics: Acetaminophen; Animals; Bromcresol Green; Electroencephalography; Evoked Potentials; Female; Indomethacin; Photic Stimulation; Probenecid; Prostaglandin Antagonists; Prostaglandins E; Prostaglandins F; Rabbits; Seizures | 1977 |
Hyperthermic effects of supracortically applied prostaglandins after systemic pretreatment with inhibitors of prostaglandin transport and synthesis.
Topics: Acetaminophen; Animals; Body Temperature; Bromcresol Green; Cerebral Cortex; Drug Interactions; Female; Indomethacin; Male; Perfusion; Probenecid; Prostaglandins; Rabbits | 1978 |
Studies on the modification of renal lesions due to aspirin and oxyphenbutazone in the rat and the effects on the kidney of 2:4 dinitrophenol.
Topics: Acetaminophen; Acute Kidney Injury; Animals; Aspirin; Dinitrophenols; Female; Kidney Tubular Necrosis, Acute; Oxyphenbutazone; Phenacetin; Probenecid; Rats | 1976 |
Intragranular starch: comparison of starch USP and modified cornstarch.
Topics: Acetaminophen; Ascorbic Acid; Biopharmaceutics; Cellulose; Chlorothiazide; Dihydroxyphenylalanine; Excipients; Hardness Tests; Kinetics; Methyldopa; Pressure; Probenecid; Solubility; Starch; Tablets | 1975 |
Influence of probenecid and paracetamol (acetaminophen) on zidovudine glucuronidation in human liver in vitro.
Topics: Acetaminophen; Adult; Aged; Glucuronates; Humans; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Middle Aged; Probenecid; Zidovudine | 1992 |
Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes.
Topics: Acetaminophen; Animals; Body Fluid Compartments; Cells, Cultured; Chromatography, High Pressure Liquid; Dideoxynucleosides; Drug Interactions; Humans; Liver; Probenecid; Rats; Rats, Inbred Strains; Zidovudine | 1991 |
Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.
Topics: 1-Methyl-3-isobutylxanthine; Acetaminophen; Acetylcysteine; Animals; Cyclic AMP; Cyclic GMP; Guanylate Cyclase; Heme; Liver; Methylnitronitrosoguanidine; Mice; Nitroglycerin; Penicillamine; Phenobarbital; Phenylhydrazines; Potassium Cyanide; Probenecid; Protoporphyrins; Purinones; S-Nitroso-N-Acetylpenicillamine | 1987 |
Salivary secretion of paracetamol in man.
Topics: Acetaminophen; Administration, Oral; Adult; Female; Half-Life; Humans; Male; Mouth Mucosa; Probenecid; Saliva; Time Factors; Trichloroacetic Acid | 1987 |
Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
Topics: Acetaminophen; Adult; Drug Interactions; Female; Glucuronates; Humans; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged; Probenecid | 1985 |
Saturable accumulation of the anionic herbicide, 2,4-dichlorophenoxyacetic acid (2,4-D), by rabbit choroid plexus: early developmental origin and interaction with salicylates.
Topics: 2,4-Dichlorophenoxyacetic Acid; Acetaminophen; Aging; Animals; Animals, Newborn; Biological Transport; Choroid Plexus; Female; Kinetics; Male; Ouabain; Probenecid; Rabbits; Sodium Salicylate; Structure-Activity Relationship | 1983 |
Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid.
Topics: Acetaminophen; Animals; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; In Vitro Techniques; Lorazepam; Macaca; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Probenecid; Rats; Rats, Sprague-Dawley | 1993 |
Acetaminophen nephrotoxicity in the CD-1 mouse. II. Protection by probenecid and AT-125 without diminution of renal covalent binding.
Topics: Acetaminophen; Aminooxyacetic Acid; Analgesics, Non-Narcotic; Animals; Binding, Competitive; Blood Urea Nitrogen; Cytosol; Enzyme Inhibitors; Glutathione; Immunohistochemistry; Injections, Intraperitoneal; Ion Transport; Isoxazoles; Kidney Tubules, Proximal; L-Iditol 2-Dehydrogenase; Liver; Male; Mice; Probenecid; Renal Agents | 1996 |
In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition.
Topics: Acetaminophen; Animals; Cytosol; Drug Antagonism; Glutathione Transferase; In Vitro Techniques; Liver; Male; Probenecid; Rats; Rats, Sprague-Dawley | 1997 |
Hepatic uptake of p-nitrophenyl sulfate by transporter that acetaminophen sulfate shares for uptake: sulfate moiety as a vector for metabolite transport.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Biological Transport, Active; Cells, Cultured; Dose-Response Relationship, Drug; Liver; Male; Nitrobenzenes; Probenecid; Rats; Rats, Wistar; Sulfates; Sulfobromophthalein | 1997 |
Inhibition of the hepatic uptake of paracetamol sulphate by anionic compounds.
Topics: Acetaminophen; Animals; Anions; Cholic Acid; Cholic Acids; Coloring Agents; Drug Interactions; Liver; Male; Nitrobenzenes; Perfusion; Probenecid; Rats; Rats, Wistar; Sulfates; Sulfobromophthalein; Uricosuric Agents | 1997 |
Probenecid protects against In vivo acetaminophen-induced nephrotoxicity in male Wistar rats.
Topics: Acetaminophen; Acute Disease; Animals; Biological Transport; Creatinine; Diuresis; Glomerular Filtration Rate; Glutathione; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Probenecid; Proteinuria; Rats; Rats, Wistar | 1998 |
Altered brain penetration of diclofenac and mefenamic acid, but not acetaminophen, in Shiga-like toxin II-treated mice.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Blood-Brain Barrier; Brain; Cyclooxygenase Inhibitors; Cytokines; Diclofenac; Male; Mefenamic Acid; Mice; Organic Anion Transporters, Sodium-Independent; Probenecid; Protein Binding; Shiga Toxin 2 | 2005 |